The researchers noted that reliance on either cJADAS10 or Wallace’s preliminary criteria alone may miss data needed for clinical treatment. Data obtained from cJADAS10 may lead to additional psychological and physiotherapy treatments not seen in Wallace’s preliminary criteria; however, “relying solely on Wallace’s preliminary criteria may guide immunosuppressive therapy very well, but may ignore other symptoms relevant to the patient.”
“As the two scores differ in their components one could argue that they are not capturing the same construct,” Ms. Shoop-Worrall and her associates wrote. “Wallace’s preliminary criteria capture more objective measures of inflammation, whilst the cJADAS10, through inclusion of a patient well-being measure, may also capture other noninflammatory components of the disease, such as chronic pain and fatigue, not captured by Wallace’s preliminary criteria.”
The authors reported having no relevant financial disclosures for this study.
SOURCE: Shoop‐Worrall SJW et al. Arthritis Rheumatol. 2018 April 12. doi: 10.1002/art.40519.